
Loading, please wait...

Loading, please wait...

Adolescent substance use behaviors represent a critical public health concern during the transition to independent driving. Consequently, understanding how these behaviors influence road safety is essential for clinicians. Notably, a recent study investigated the correlation between alcohol and cannabis use and risky driving habits. Furthermore, researchers examined the role of peer influence and individual risk perceptions. However, many teens still underestimate the dangers of driving under the influence. Therefore, identifying high-risk individuals early is vital for preventing life-altering accidents.
The study reveals that nearly 22% of adolescent participants reported riding with an impaired driver. Furthermore, 3.6% endorsed driving under the influence in their lifetime. These findings suggest that adolescent substance use behaviors are deeply intertwined with permissive attitudes toward safety. In addition, adolescents who perceived cannabis or alcohol impairment as low-risk were significantly more likely to engage in these behaviors. Consequently, driver education programs must incorporate strategies to correct these misconceptions. Furthermore, pediatricians and family doctors should utilize routine visits to screen for substance use and discuss road safety with both patients and parents.
Healthcare providers play a pivotal role in mitigating these risks. Additionally, family and peer influences strongly dictate how teens perceive safety boundaries. Moreover, school-based education platforms can effectively challenge cannabis-related permissive attitudes. Therefore, a multidisciplinary approach is necessary to ensure the safety of novice drivers. Clinicians should emphasize that any level of impairment significantly delays reaction times and compromises decision-making on the road.
Riding with an impaired driver (RWID) is highly prevalent, with over 20% of adolescents reporting this behavior, often due to social pressure or low risk perception.
Adolescents who view the effects of alcohol or cannabis as manageable are significantly more likely to drive impaired or accept rides from impaired peers.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Tran S et al. Characteristics associated with alcohol and cannabis-related impaired risky driving and riding behaviors among adolescents. Traffic Inj Prev. 2026 Mar 11. doi: 10.1080/15389588.2026.2628957. PMID: 41811351.
Dhawan A, Chatterjee B, Bhargava R, Chopra A, Mandal P, Rao R, et al. Substance use among school-going adolescents in India: Results from a nationwide survey. Natl Med J India 2025;38: 332–8. doi: 10.25259/NMJI_824_2022.
Barr HK, Clements-Nolle K, Lensch T, Yang W. Risk and Protective Factors for Driving Under the Influence of Alcohol, Marijuana, and Both Substances in a Population-Based Sample of High School Students. J Child Adolesc Subst Use. 2025;30(1):2-12. doi: 10.1080/1067828X.2024.2391127.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Study analyzes the link between alcohol/cannabis use and risky driving among novice drivers, emphasizing the importance of correcting risk perceptions....
7 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today